HB1638
Interim Study (House)creating a bypass mechanism for health insurer step therapy protocols when medically necessary.
Status
Hearing
No upcoming hearing scheduled.
Testimony
51 total submissions
Bill Docket
Interim Study Report: Not Recommended for Future Legislation 10/15/2026 (Vote 11-0; )
HouseOctober 19, 2026
Executive Session: 10/14/2026 10:00 am GP 229
HouseOctober 01, 2026
Subcommittee Work Session: 10/07/2026 10:00 am GP 229
HouseSeptember 17, 2026
Subcommittee Work Session: 09/09/2026 10:00 am GP 229
HouseAugust 21, 2026
Public Hearing: 02/17/2026 11:00 am GP 159
HouseAugust 05, 2026
Refer for Interim Study: MA VV 03/11/2026 HJ 7 P. 13
HouseMarch 11, 2026
Committee Report: Refer for Interim Study 02/18/2026 (Vote 15-0; CC) HC 10 P. 9
HouseMarch 03, 2026
Executive Session: 02/18/2026 01:00 pm GP 229
HouseFebruary 11, 2026
Full Committee Work Session: 02/18/2026 10:00 am GP 229
HouseFebruary 11, 2026
Introduced 01/07/2026 and referred to Commerce and Consumer Affairs HJ 1 P. 29
HouseDecember 10, 2025